We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.03B
AUM Growth
+$589M
Cap. Flow
+$81.4M
Cap. Flow %
1.35%
Top 10 Hldgs %
18.86%
Holding
1,529
New
146
Increased
642
Reduced
570
Closed
93

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Financials 10.31%
3 Industrials 8.91%
4 Healthcare 8.6%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VHT icon
501
Vanguard Health Care ETF
VHT
$18.2B
$2.07M 0.03%
7,643
-145
-2% -$38.1K
JKHY icon
502
Jack Henry & Associates
JKHY
$10.9B
$2.07M 0.03%
11,896
+370
+3% +$63K
ADSK icon
503
Autodesk
ADSK
$49.5B
$2.06M 0.03%
7,897
+1,428
+22% +$361K
DRI icon
504
Darden Restaurants
DRI
$23.4B
$2.05M 0.03%
12,294
-265
-2% -$44K
MET icon
505
MetLife
MET
$62.2B
$2.05M 0.03%
27,662
+477
+2% +$33.2K
CGDV icon
506
Capital Group Dividend Value ETF
CGDV
$37.6B
$2.04M 0.03%
62,894
+4,905
+8% +$151K
ON icon
507
ON Semiconductor
ON
$32.6B
$2.04M 0.03%
27,781
-2,988
-10% -$229K
AKAM icon
508
Akamai
AKAM
$16.7B
$2.04M 0.03%
18,757
+89
+0.5% +$10.3K
ICVT icon
509
iShares Convertible Bond ETF
ICVT
$7.23B
$2.04M 0.03%
25,551
+827
+3% +$64.6K
ARM icon
510
Arm
ARM
$261B
$2.03M 0.03%
16,249
+911
+6% +$96.5K
INGR icon
511
Ingredion
INGR
$6.28B
$2.03M 0.03%
17,353
+296
+2% +$33.3K
CRSP icon
512
CRISPR Therapeutics
CRSP
$4.73B
$2.02M 0.03%
29,692
+3,257
+12% +$233K
UI icon
513
Ubiquiti
UI
$33.4B
$2.02M 0.03%
17,466
-724
-4% -$88.8K
SMDV icon
514
ProShares Russell 2000 Dividend Growers ETF
SMDV
$694M
$2.02M 0.03%
31,564
+2,346
+8% +$146K
LAMR icon
515
Lamar Advertising Co
LAMR
$16.2B
$2.02M 0.03%
16,896
-3,998
-19% -$438K
ALL icon
516
Allstate
ALL
$68.4B
$2.01M 0.03%
11,621
+227
+2% +$35.8K
CEMB icon
517
iShares JPMorgan EM Corporate Bond ETF
CEMB
$398M
$2.01M 0.03%
45,154
+7,366
+19% +$325K
PNC icon
518
PNC Financial Services
PNC
$99.7B
$2.01M 0.03%
12,419
-61
-0.5% -$9.19K
UGI icon
519
UGI
UGI
$7.76B
$2M 0.03%
81,449
+68,984
+553% +$1.66M
INDA icon
520
iShares MSCI India ETF
INDA
$6.9B
$2M 0.03%
38,684
+14,192
+58% +$716K
XLG icon
521
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
$1.98M 0.03%
47,033
+25,841
+122% +$1.04M
NML
522
Neuberger Energy Infrastructure and Income Fund Inc
NML
$585M
$1.98M 0.03%
268,477
+54,136
+25% +$371K
HYLS icon
523
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
$1.98M 0.03%
47,944
+12,025
+33% +$495K
MCK icon
524
McKesson
MCK
$101B
$1.97M 0.03%
3,672
+2,473
+206% +$1.26M
TMDX icon
525
Transmedics
TMDX
$2.62B
$1.96M 0.03%
26,570
+16,214
+157% +$1.34M

Similar funds

Oppenheimer & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Oppenheimer & Co held 1,529 positions worth $6.03B, up 11% from $5.44B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co's Q1 2024 filing shows 146 new, 642 increased, 570 reduced and 93 closed positions. Its largest new stake was State Street SPDR Portfolio Long Term Treasury ETF: 116,262 shares worth $3.25M. The largest sale was NVIDIA, an estimated $8.83M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q1 2024 buy was State Street SPDR Portfolio Long Term Treasury ETF: 116,262 shares worth $3.25M.
  • Oppenheimer & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $7.26M increase.
  • Oppenheimer & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $8.83M.
  • Oppenheimer & Co fully exited Pacer Developed Markets International Cash Cows 100 ETF in Q1 2024, selling an estimated $2.89M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $6.03B portfolio in Q1 2024.
  • Oppenheimer & Co opened 146 new positions and closed 93 in Q1 2024.
  • Oppenheimer & Co's portfolio value rose 11% quarter-over-quarter to $6.03B.

Based on Oppenheimer & Co's 13F filing for Q1 2024, filed 7 May 2024.